Immunosuppression for progressive membranous nephropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN99959692

Enrollment

120

Registered

2000-10-25

Start date

1999-01-15

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Progressive membranous glomerulonephritis Urological and Genital Diseases Progressive membranous glomerulonephritis

Interventions

Randomisation will be between three groups: 1. One receiving supportive treatment only 2. One receiving 12 months treatment with cyclosporin 3. One receiving six months treatment with a combination of

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Idiopathic membranous nephropathy with a 20% decline in glomerular filtration rate 2. Patients aged between 18 and 75

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Glomerular filtration rate with a further decline of 20% being an end-point	—

Secondary

Measure	Time frame
Proteinurea and adverse effects	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026